1000 Participants Needed

Chemotherapy for Cancer

Recruiting at 2 trial locations
CT
Overseen ByClinical Trials Referral Office
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand why some cancer patients experience heart problems after chemotherapy while others do not. Researchers will collect blood samples and review medical records to identify patterns or markers that might predict these heart issues. The trial seeks participants who have undergone chemotherapy, regardless of whether they have experienced heart problems, as well as those about to start treatments known to affect the heart. Joining this trial could help uncover ways to prevent or manage heart-related side effects of cancer treatment. As an unphased study, this trial offers a unique opportunity to contribute to groundbreaking research that could improve heart health for cancer patients.

Why are researchers excited about this trial?

Researchers are excited about this trial because it aims to find new ways to predict heart problems caused by cancer treatments. Unlike existing methods that focus on treating heart issues after they appear, this study looks at identifying biomarkers—specific indicators in the blood that can flag potential heart damage early. This proactive approach could help doctors tailor cancer treatments more safely, minimizing risks and enhancing patient care.

Who Is on the Research Team?

NN

Nadine Norton, PhD

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

Inclusion Criteria

I understand the study's procedures, risks, and discomforts.
I have been treated for cancer with chemotherapy or immunotherapy.
I have heart issues from cancer treatment or will start treatment that could affect my heart.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observation

Patients undergo blood sample collection and have their medical records reviewed

Baseline

Follow-up

Participants are monitored for any changes in heart function following chemotherapy

4 weeks

What Are the Treatments Tested in This Trial?

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: ObservationalExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+